Mergers + Acquisitions | China

Filter Results

Morrison & Foerster's China M&A practice combines senior PRC regulatory expertise with international deal execution capability. Our attorneys in Beijing, Shanghai, and Hong Kong have significant PRC-related cross-border M&A experience. The firm is recognized by a number of independent ranking organizations such as Chambers Asia, IFLR1000, Asia Pacific Legal 500, and Asialaw as a leading law firm for mergers and acquisitions in China and Hong Kong. We are ranked in The Elite for Corporate/ M&A International Firm in China by Chambers Asia Pacific 2018. A client was quoted that: "I cannot speak more highly of them. They understand what we are trying to achieve and they think ahead about our interests."

Notable Matters

  • SoftBank/US$4 Billion Restructuring of We represented SoftBank in the Alibaba Group's $4 billion restructuring of its holdings in Alipay, China's largest online payment system, to address regulatory requirements relating to foreign ownership of online payment systems in China.
  • Kirin Holdings Company/Beverage Joint Venture with China Resources. Advised Kirin Holdings Company, Limited (Kirin), a leading Japanese company in the global food and beverage market, in its US$400 million strategic joint venture with China Resources Enterprise, a Hong Kong-based consumer goods company operating in the retail, beer, food and beverage markets throughout China. The joint venture will manufacture and distribute non-alcoholic beverages throughout Greater China, including Hong Kong and Macau.
  • Intel Corp./US$1.4 Billion Acquisition of Infineon's Wireless Solutions Business. Advised Intel in its US$1.4 billion acquisition of the Wireless Solutions business unit of German chip maker Infineon Technologies AG, a spinoff of Siemens AG and Europe's second-largest semiconductor manufacturer. The Infineon deal was a challenging acquisition with numerous cross-border issues. The China team handled all aspects of the transaction in the PRC, including matters relating to the transferred assets, employees, premises, intellectual property and transitional matters. This transaction is part of Intel's stated strategy to grow its revenues and its business in mobile computing, smartphones, tablets, and embedded computing in the software industry.
  • Harbin Pharmaceutical Acquisition of Pfizer Vaccine Business. Advised one of the largest pharmaceutical companies in China, Harbin Pharmaceutical, in its asset acquisition of Pfizer's swine vaccine business in China. This is the first MOFCOM-ordered divestment of its kind. Financial Times refers to this transaction as a "watershed Chinese deal…the first of many such transfers of western IP to Chinese groups arising from local competition rulings."
  • Rakuten JV with Baidu, Inc. Advising Rakuten with respect to its JV with Baidu, Inc., the leading Chinese language Internet service provider, to build a B2B2C online shopping mall for Chinese Internet users.
  • CR Power/US$669 Million Acquisition of Banpu's Coal Assets in China. Advised Hong Kong-listed China Resources Power Holdings Company Limited in its US$669 million acquisition of a 56% stake in Daning coal mine in Shanxi Province, northern China from Banpu Public Company Limited, a major Thailand-based natural resources company. The acquisition is part of CR Power's efforts to secure and expand it coal supply base for its power generation business.

Chambers Global 2018 and Chambers Asia-Pacific 2018
Asia-Pacific: Corporate/M&A
China: Corporate/M&A: The Elite: International Firms

IFLR1000 2018
China: M&A: Foreign Firms
Hong Kong: M&A

Legal 500 Asia-Pacific 2018
China: Corporate/M&A: Foreign Firms
Hong Kong: Corporate (including M&A)

ALB Hong Kong Law Awards 2018
Deal Firm of the Year

League Tables:

Bloomberg M&A League Table Ranking 2018

  • The #1 law firm by M&A deal volume and market share in Asia Pacific

Bloomberg M&A League Table Ranking 2017

  • The #1 law firm by private equity deal value in Asia Pacific
  • The #1 international law firm by deal value and deal count in Japan
  • The #3 law firm by M&A deal value in Asia Pacific
  • The #6 law firm by M&A deal value in Asia ex Japan  

Thomson Reuters M&A League Table Ranking 2018

  • The #1 law firm for Chinese involvement by deal value
  • The #1 law firm for Asia Pacific emerging market involvement by deal value
  • The #2 law firm for emerging market involvement by deal value
  • The #2 law firm for any BRIC involvement by deal value
  • The #4 law firm for any Asian (excluding-Japan) involvement by deal value and deal count 

Here is what they say about us:

"Significant M&A clientele, including corporate heavyweights across Asia."
(Chambers Asia-Pacific 2018)

Filter Results

China: Corporate/ M&A: The Elite (International Firms)
(Chambers Asia-Pacific 2018)

"Significant M&A clientele, including corporate heavyweights across Asia."

"Quite a few international firms are good; however, 'the efficiency of MoFo is more impressive'."
(Chambers Asia-Pacific 2018)

"MoFo impressed me with their ability to harness the knowledge of their overseas offices in providing some remarkable advice" a client enthuses.
(Chambers Global 2018)

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2019 Morrison & Foerster LLP. All rights reserved.